by Brian Shilhavy
Editor, Health Impact News
April 24, 2021
from
HealthImpactNews Website
The European database
of suspected drug reaction reports
is EudraVigilance,
which also tracks reports
of injuries and deaths
following the experimental
COVID-19
"vaccines"...
Here is what EudraVigilance states
about their database:
This website
was launched by the European
Medicines Agency in 2012 to provide public access to
reports of suspected side effects (also known as
suspected adverse drug reactions).
These reports are submitted
electronically to EudraVigilance by
national medicines regulatory authorities and by pharmaceutical
companies that hold marketing authorizations (licences) for the
medicines.
EudraVigilance
is a system designed for collecting reports of suspected side
effects.
These reports are used for evaluating the benefits and
risks of medicines during their development and monitoring their
safety following their authorisation in the European Economic
Area (EEA).
EudraVigilance has been in use since December 2001.
This website
was launched to comply with the EudraVigilance
Access Policy, which was developed to improve public health
by supporting the monitoring of the safety of medicines and to
increase transparency for stakeholders, including the general
public.
The Management
Board of the European Medicines Agency first approved the
EudraVigilance Access Policy in December 2010.
A
revision was adopted by the Board in December 2015 based on the
2010 pharmaco-vigilance legislation. The policy aims to
provide stakeholders such as national medicines regulatory
authorities in the EEA, the European Commission, healthcare
professionals, patients and consumers, as well as the
pharmaceutical industry and research organizations, with access
to reports on suspected side effects.
Transparency is
a key guiding principle of the Agency, and is pivotal to
building trust and confidence in the regulatory process.
By
increasing transparency, the Agency is better able to address
the growing need among stakeholders, including the general
public, for access to information.
(Source)
Their report
through April 17, 2021 lists 7,766 deaths
and 330,218 injuries following injections of four
experimental COVID-19
shots:
-
COVID-19 MRNA VACCINE MODERNA
(CX-024414)
-
COVID-19 MRNA VACCINE PFIZER-BIONTECH
-
COVID-19 VACCINE ASTRAZENECA
(CHADOX1 NCOV-19)
-
COVID-19 VACCINE JANSSEN
(AD26.COV2.S)
A Health Impact
News subscriber in Europe ran the reports for each of the four
COVID-19 shots we are including here.
This subscriber has
volunteered to do this, and it is a lot of work to tabulate each
reaction with injuries and fatalities, since there is no place on
the EudraVigilance system
we have found that tabulates all the results.
Here is the summary
data through April 17, 2021:
Total
reactions for the
experimental mRNA vaccine Tozinameran (code BNT162b2, Comirnaty)
from BioNTech/ Pfizer:
4,293 deaths
144,607
injuries to 17/04/2021
-
10,754
Blood and lymphatic system disorders
incl. 37 deaths
-
6,993
Cardiac disorders
incl. 499 deaths
-
45 Congenital, familial and genetic disorders
incl. 2 deaths
-
3,944
Ear and labyrinth disorders
incl. 3 deaths
-
103
Endocrine disorders
-
4,388
Eye disorders
incl. 5 deaths
-
32,024
Gastrointestinal disorders
incl. 216 deaths
-
99,747
General disorders and administration site conditions
incl. 1397 deaths
-
199
Hepatobiliary disorders
incl. 15 deaths
-
3,165
Immune system disorders
incl. 19 deaths
-
9,534
Infections and infestations
incl. 512 deaths
-
3,653
Injury, poisoning and procedural complications
incl. 79 deaths
-
7,166
Investigations
incl. 161 deaths
-
2,407
Metabolism and nutrition disorders
incl. 85 deaths
-
51,699
Musculoskeletal and connective tissue disorders
incl. 44 deaths
-
133
Neoplasms benign, malignant and unspecified (incl cysts and
polyps) incl. 7
deaths
-
63,051
Nervous system disorders
incl. 393 deaths
-
177
Pregnancy, puerperium and perinatal conditions
incl. 7 deaths
-
76 Product issues
-
5,684
Psychiatric disorders
incl. 60 deaths
-
885
Renal and urinary disorders
incl. 62 deaths
-
911
Reproductive system and breast disorders
incl. 1 death
-
13,181
Respiratory, thoracic and mediastinal disorders
incl. 490 deaths
-
15,325
Skin and subcutaneous tissue disorders
incl. 35 deaths
-
409
Social circumstances
incl. 6 deaths
-
111
Surgical and medical procedures
incl. 6 deaths
-
7,694
Vascular disorders
incl. 152 deaths
Total
reactions for the
experimental mRNA vaccine mRNA-1273(CX-024414) from Moderna:
2,094
deaths
15,979 injuries to 17/04/2021
-
766
Blood and lymphatic system disorders
incl. 14 deaths
-
1,184
Cardiac disorders
incl. 206 deaths
-
8 Congenital, familial and genetic disorders
incl. 2 deaths
-
339
Ear and labyrinth disorders
-
20 Endocrine disorders
-
518
Eye disorders
incl. 3 deaths
-
3,523
Gastrointestinal disorders
incl. 75 deaths
-
11,366
General disorders and administration site conditions
incl. 938 deaths
-
69 Hepatobiliary disorders
incl. 3 deaths
-
439
Immune system disorders
incl. 1 death
-
1,299
Infections and infestations incl.
107 deaths
-
707
Injury, poisoning and procedural complications
incl. 41 deaths
-
5356
Investigations
incl. 58 deaths
-
472
Metabolism and nutrition disorders
incl. 42 deaths
-
5,163
Musculoskeletal and connective tissue disorders
incl. 44 deaths
-
46 Neoplasms benign, malignant and unspecified (incl
cysts and polyps)
incl. 7 deaths
-
6,834
Nervous system disorders
incl. 215 deaths
-
44 Pregnancy, puerperium and perinatal conditions
-
8 Product issues
-
782
Psychiatric disorders
incl. 31 deaths
-
271
Renal and urinary disorders
incl. 20 deaths
-
96 Reproductive system and breast disorders
incl. 1 death
-
2,019
Respiratory, thoracic and mediastinal disorders
incl. 181 deaths
-
1,947
Skin and subcutaneous tissue disorders
incl. 19 deaths
-
151
Social circumstances
incl. 6 deaths
-
100
Surgical and medical procedures
incl. 12 deaths
-
1,035
Vascular disorders
incl. 68 deaths
Total
reactions for the
experimental vaccine AZD1222/VAXZEVRIA (CHADOX1
NCOV-19) from Oxford/AstraZeneca:
1,360 deaths
169,386 injuries to 17/04/2021
-
4,740
Blood and lymphatic system disorders
incl. 61 deaths
-
6,744
Cardiac disorders
incl. 172 deaths
-
67 Congenital, familial and genetic disorders
incl. 2 death
-
4,480
Ear and labyrinth disorders
-
127
Endocrine disorders
incl. 2 deaths
-
6,983
Eye disorders
incl. 5 deaths
-
52,560
Gastrointestinal disorders
incl. 54 deaths
-
130,827General disorders and administration site conditions
incl. 442
deaths
-
203
Hepatobiliary disorders
incl. 6 deaths
-
1,666
Immune system disorders
incl. 6 deaths
-
9,789
Infections and infestations
incl. 88 deaths
-
3,736
Injury, poisoning and procedural complications
incl. 16 deaths
-
8,792
Investigations
incl. 19 deaths
-
6,575
Metabolism and nutrition disorders
incl. 14 deaths
-
76,467
Musculoskeletal and connective tissue disorders
incl. 13 deaths
-
125
Neoplasms benign, malignant and unspecified (incl cysts and
polyps) incl. 3
deaths
-
103,240Nervous system disorders
incl. 207 deaths
-
88 Pregnancy, puerperium and perinatal conditions
-
42 Product issues
-
8,740
Psychiatric disorders
incl. 10 deaths
-
1,609
Renal and urinary disorders
incl. 10 deaths
-
1,688
Reproductive system and breast disorders
-
14,224
Respiratory, thoracic and mediastinal disorders
incl. 130 deaths
-
21,280
Skin and subcutaneous tissue disorders
incl. 9 deaths
-
330
Social circumstances
incl. 3 deaths
-
351
Surgical and medical procedures
incl. 10 deaths
-
7,427
Vascular disorders
incl. 78 deaths
Total
reactions for the
experimental COVID-19 vaccine JANSSEN (AD26.COV2.S) from Johnson
& Johnson:
19 deaths
246
injuries to 17/04/2021
(No graph yet)
-
9 Blood and lymphatic system disorders
incl. 1 death
-
29 Cardiac disorders
incl. 5 deaths
-
1 Congenital, familial and genetic disorder
-
16 Ear and labyrinth disorders
-
1 Endocrine disorder
-
14 Eye disorders
-
61 Gastrointestinal disorders
-
154
General disorders and administration site conditions
incl. 8 deaths
-
4 Hepatobiliary disorders
-
10 Immune system disorders
-
27 Infections and infestations
-
16 Injury, poisoning and procedural complications
-
40 Investigations
-
12 Metabolism and nutrition disorders
-
59 Musculoskeletal and connective tissue disorders
-
0 Neoplasms benign, malignant and unspecified (incl
cysts and polyps)
-
138
Nervous system disorders
incl. 1 death
-
0 Pregnancy, puerperium and perinatal conditions
-
1 Product issue
-
24 Psychiatric disorders
-
9 Renal and urinary disorders
incl. 1 death
-
4 Reproductive system and breast disorders
-
49 Respiratory, thoracic and mediastinal disorders
incl.
1 death
-
28 Skin and subcutaneous tissue disorders
-
4 Social circumstances
-
4 Surgical and medical procedures
-
44 Vascular disorders
incl. 2 deaths
This is public
information funded by the European Medicines Agency (EMA), and
anyone can use the EudraVigilance system
and verify this data.
Denmark
and
Norway have completely suspended use of the AstraZeneca
experimental COVID-19 shots.
A statement issued
by the Norwegian
Institute of Public Health stated that the AstraZeneca COVID "vaccine" is more dangerous than COVID itself, especially for young
people.
The EMA continues
to recommend it.
They did, however,
add a safety warning to the J&J
shots, due to fatal blood clots...
(Source)
5 Doctors Agree that...
COVID-19 Injections are Bioweapons
and Discuss What to do About It
and More...
Click
above image for additional related information...
|